News

Latest News:

mc2_news-image-icon-07

Professor Lars Iversen joins MC2 Therapeutics as new Chief Medical Officer

POSTED: June 9, 2022

Copenhagen, June 9th 2022 – MC2 Therapeutics A/S, a commercial stage pharmaceutical company, has named Lars Iversen, MD, DMSc an esteemed chair professor in dermatology at Aarhus University Hospital and ...

READ FULL ARTICLE >

Upcoming Events:

February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

READ MORE >

August 11th, 2021

MC2 Therapeutics is proud to support National Psoriasis Action Month

READ MORE >

July 23, 2021

MC2 Therapeutics supports World Sjögren’s Day

READ MORE >